Autoimmune Disease
News on research and diagnostics in autoimmune disorders including rheumatoid arthritis, lupus, multiple sclerosis, and more.
PolTreg T-Regulatory Cell Therapy Shows Clinical Remission in Type 1 Diabetes for up to 12 Years
The company is now seeking partnership funding to launch a pivotal Phase II/III study of the autologous T-regulatory cell therapy.
Sonoma Bio Receives $45M Milestone Payment From Regeneron
The payment was triggered when Sonoma achieved a milestone related to an unspecified autologous Tregcell therapy it is developing with Regeneron.
First Patient Dosed in Phase I Trial of Cartesian Therapeutics' Anti-BCMA mRNA CAR T-Cell Therapy
The trial will examine the safety and tolerability of Descartes-15 in patients with relapsed or refractory multiple myeloma.
FDA Approves Iaso Bio IND to Test CAR T-Cell Therapy in New Autoimmune Indications
The firm will test eque-cel, which is approved as a treatment for multiple myeloma in China, in systemic lupus erythematosus and lupus nephritis.
The New Jersey hospital system is enrolling patients into a Phase I clinical trial evaluating Bristol Myers Squibb's investigational cell therapy for lupus.